SAMUEL
NAVARRO FOS
CATEDRÁTICO/A DE UNIVERSIDAD


Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia
Valencia, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (10)
2025
-
Risk of developing neuroblastoma influenced by maternal stressful life events during pregnancy and congenital pathologies
Pediatric Blood and Cancer, Vol. 72, Núm. 2
-
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis
Neoplasia (United States), Vol. 60
2024
-
Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines
Cancers, Vol. 16, Núm. 19
-
Rare mediastinal small round cell melanoma with synovial sarcoma-like immunophenotype: A potential diagnostic pitfall
Pathology Research and Practice, Vol. 262
-
Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?
International Journal of Molecular Sciences, Vol. 25, Núm. 16
2023
-
Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma
Computers in Biology and Medicine, Vol. 164
2019
-
Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diagnosis
International Journal of Surgical Pathology, Vol. 27, Núm. 5, pp. 568-573
-
Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens
Histopathology, Vol. 75, Núm. 4, pp. 517-525
-
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression
Modern Pathology, Vol. 32, Núm. 2, pp. 306-313
2016
-
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology
Oncotarget, Vol. 7, Núm. 16, pp. 22543-22555